Beyond protein: what really matters for healthy aging

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

As protein becomes the latest nutrition obsession, experts unpack what actually keeps us healthy as we age, from movement to food to habits.

If you spend enough time online, it can start to feel as though healthy aging has been reduced to a single question: how much protein did you eat today?

Protein bars have become breakfast. Protein water sits beside the soft drinks. Even familiar snacks are being reformulated and relabelled around their protein content. Somewhere along the way, a nutrient that has always been important became a kind of nutritional celebrity.

In the latest episode of Longevity.Technology UNLOCKED, the conversation takes a step back. Dr Christopher Gardner, Dr Stuart Phillips and Dr Tom Rifai are not arguing that protein does not matter. They are asking a more useful question: what happens when we mistake one piece of the longevity puzzle for the whole picture?

For Phillips, a leading researcher in muscle, aging, exercise and protein metabolism, the answer begins with something considerably less marketable than a protein shake.

“Exercise is the big, if you want, non-negotiable to me,” he says. “Protein helps.” That distinction becomes increasingly important as weight-loss drugs, particularly GLP-1s, change how millions of people approach obesity and metabolic health.

Muscle is more than what you see in the mirror

Muscle is easy to think about aesthetically. Bigger biceps, stronger legs, a leaner physique. But Phillips sees it as something much more fundamental: a kind of metabolic infrastructure.

Muscle helps us move through the world, but it also plays an important role in controlling blood glucose. Because it is such a large tissue, active muscle takes up a substantial amount of glucose after we eat. It also contributes significantly to resting energy expenditure.

The practical implication is straightforward. Muscle is not simply something to preserve for appearance or athletic performance. It helps keep the body functional. And that becomes particularly important with age.

Phillips describes the decline in muscle and mobility as a point where quality of life can begin to narrow. Once movement becomes difficult, the consequences extend beyond physical strength. Getting around becomes harder. Social interaction can shrink. Everyday independence can become more fragile. That is why he is cautious about turning protein into the hero of the story.

“We’ve lost the plot as far as protein is concerned,” Phillips says. His point is not that people should stop thinking about protein. Rather, protein needs somewhere to go. Resistance exercise gives muscle the signal to use it.

Think of protein as building material and exercise as the construction order. Having more bricks delivered to a building site does not accomplish much if nobody is actually building anything.

The GLP-1 question needs more nuance

Weight loss, whether achieved through medication, diet or increased energy expenditure, can involve losses in lean tissue alongside fat. That has prompted understandable concern about muscle. But the podcast’s discussion pushes back against the idea that every reduction in lean mass automatically represents a looming public-health disaster.

Phillips points out that the tools commonly used to measure lean mass cannot always tell us precisely how much actual muscle has been lost. Lean mass includes much more than muscle, including water, organs, skin and connective tissue.

“We actually don’t know whether GLP-1s cause loss of muscle,” he says. “They probably do, but we don’t know whether that’s the case.” That uncertainty is important. So is the other side of the equation: weight loss itself can improve metabolic health.

The better question, then, is not whether GLP-1 users should fear losing muscle. It is whether weight-loss treatment should be accompanied by the things that help people maintain function: appropriate nutrition, resistance exercise and broader lifestyle support.

Rifai puts it bluntly. GLP-1s are “turbochargers”, but “the engine is really lifestyle”. It is a useful analogy because it avoids both extremes. Medication does not need to be dismissed as somehow illegitimate, nor should it become a substitute for everything else that keeps the body healthy.

No single diet hiding at the finish line

The same principle applies to nutrition itself. Gardner has spent decades studying different dietary patterns, from ketogenic and low-carb diets to Mediterranean and vegan approaches. One of his biggest lessons is how misleading dietary labels can be.

A person can technically follow a vegan diet while eating highly processed food all day. Someone can call their diet Mediterranean while consuming very little that resembles the traditional pattern.

“You have to probe a little deeper,” Gardner says.

When healthy versions of different dietary patterns are compared, the differences can become surprisingly small. Gardner points to common ground across popular diets: more vegetables, more whole foods, less added sugar and fewer refined grains.

None of that is particularly revolutionary. It is also not particularly clickable. That may be precisely why it gets overlooked.

Rifai sees another problem when supposedly universal dietary advice ignores culture. He recalls a patient who became emotional when asked about her own food preferences because she had assumed the doctor would put her on what she called the “whitey diet” – the Mediterranean diet.

For Rifai, the lesson was clear: patients are not passive recipients of nutritional instructions.

“They have agency,” he says. “I’m not there to tell them what to do. I’m there to give them information, and then they decide.”

That idea may be one of the most important pieces of longevity advice in the entire conversation. A theoretically perfect diet that someone cannot afford, enjoy or sustain is not particularly useful.

The real longevity hack may be remarkably ordinary

The further the conversation moves, the less it sounds like a battle between competing diets and the more it resembles a case for getting the fundamentals right.

Gardner describes healthy eating as something that can accommodate culture, preference, allergies and budget. Rifai talks about the environment around us, from the food available at home to the people who influence our habits. And both point toward something that the longevity industry can sometimes obscure: health is lived in ordinary moments.

It happens when you decide what to buy at the supermarket. When you cook dinner instead of reaching for whatever is easiest. When you walk, lift something heavy, climb stairs or stay physically active throughout the day. When you eat with other people rather than treating food as fuel to be consumed between meetings.

Phillips makes a similar observation when discussing so-called Blue Zones. Their common features are hardly futuristic: minimally processed foods, plenty of plant foods, physical activity and strong social networks.

There is an irony here. An industry increasingly fascinated by optimisation can end up overlooking the things that do not need optimisation at all.

Perhaps healthy aging requires building a life in which good food, movement, relationships and sustainable habits are normal enough that they do not need to be constantly tracked, hacked or reinvented.

Gardner’s final thought is perhaps the simplest way to approach it. Food, he says, gives us “a do-over every single day”.

That is a more forgiving vision of longevity than the internet usually offers.

You do not have to get everything right today. You do not need the perfect protein target, the perfect diet label or the perfect routine. You can make one useful change, learn from it and make another tomorrow.

For a field obsessed with extending the future, something is refreshing about advice that begins with what we can do today.

Listen to Longevity.Technology UNLOCKED every Monday on Apple Podcasts, Spotify and YouTube, featuring conversations with the researchers, clinicians and innovators shaping the future of healthy aging. Then join us every Friday for the latest longevity news.

Kyle Umipig

Kyle has nine years of editorial writing experience. They have been following the longevity sector since 2022, focusing on research, emerging tech, and the companies shaping the future of aging and age-related health.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Alzheimer’s drug market faces a $14.7bn future

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE